EEversens
Eversens is a Spanish medtech company that designs, develops, manufactures, and commercializes non-invasive breath-analysis devices for detecting exhaled biomarkers, used to diagnose and monitor respiratory diseases like asthma. Its flagship product, evernoa BASE, measures fractional exhaled nitric oxide (FeNO), a biomarker for airway inflammation. Founded in 2015 as a spin-off of the Public University of Navarra (UPNA), it is ISO 13485:2018 certified and based in Pamplona.
SectorsMedtech, Diagnostics, Respiratory health, Biosensors
Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing
Founders
F
Francisco J. Arregui
Co-Founder
I
Ignacio R. Matías
Co-Founder
J
Juan Mari Pérez Azpeitia
Co-Founder & CTO
L
Leyre Ruete Ibarrola
CEO & Founding Partner
Global models 3
OOwlstone Medical
United Kingdom · www.owlstonemedical.com ↗
Owlstone Medical develops and sells breath-analysis devices that detect exhaled biomarkers to diagnose and monitor disease, including respiratory conditions, which is the same device model as Eversens.
$170M+Comparable
AAerocrine
Sweden · www.niox.com ↗
Aerocrine was the VC-backed company that created the NIOX FeNO device for measuring airway inflammation in asthma, making it the most direct precedent for Eversens's evernoa.
$150M+Comparable
BBreathonix
Singapore · www.breathonix.com ↗
Breathonix is a university spin-off that builds and sells breath-analysis diagnostic devices based on exhaled biomarkers, which is the same model as Eversens.
$10MComparable
In the same niche 48 others
See all in the Start-ups Map →Notes: Most funded first
Investors 5
Open as list →Funding rounds 4
·1 not counted| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-18 | Seed | €250K partial: only one investor's ticket was disclosed |
Lead not disclosed
+3 more
|
| 2020-07-01 | Seed (estimated) | €356K |
Lead not disclosed
+4 more
|
| 2018-06-08 | Seed | €340K |
Lead not disclosed
+3 more
|
| 2017-11-06 | Seed (estimated) | €630K |
Lead not disclosed
+2 more
|
News 4
Open as list →| Published | Article |
|---|---|
| 2026-07-23 |
Navarra investiga el sentido del olfato para anticipar el diagnóstico de enfermedades como el Alzheimer ↗
Noticias de Navarra
2026-07-23 |
| 2025-02-26 |
The BREATHE Project: Artificial Intelligence for a Future Without Respiratory Exacerbations ↗
4YFN (Mobile World Capital)
2025-02-26 |
| 2024-10-10 |
Eversens obtiene 356.000 euros en una ronda de financiación ↗
Navarra Capital
2024-10-10 |
| 2023-10-18 |
Leyre Ruete Ibarrola Presents everSens at LSI Europe '23 ↗
Life Science Intelligence
2023-10-18 |









